Abstract
A 63-year-old healthy woman presented for routine diabetes screening as part of an annual wellness exam. She has no personal or family history of diabetes or anemia. Her hemoglobin (Hb)2 concentration was 13.4 g/dL. Her hemoglobin A1c (HbA1c) was strikingly high, at 25.4% (reportable range, 3.5%–19%), measured by the cation-exchange high-performance liquid chromatography (HPLC) method (Variant II Turbo, Bio-Rad). The WHO recommendations for use of HbA1c to diagnose diabetes mellitus use a cutoff of 15% is flagged for review. Of note, the patient had a normal fasting glucose and HbA1c in the past 2 years. This year, our laboratory switched HbA1c measurement from an immunoturbidimetric method (Tina-quant, Roche) to an HPLC method. The HPLC chromatogram of her HbA1c result showed a decreased fraction of nonglycohemoglobin A (HbA), and no variant peak was identified (Fig. 1). HbA1c is calculated as a percentage of the area of the “A1c” peaks in relation to the total area of hemoglobin peaks on the chromatogram. Fig. 1. HbA1c result of 25.4% measured by the HPLC method. Despite the …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
